You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR ROBAXIN-750


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ROBAXIN-750

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02432456 ↗ Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients Completed Medical College of Wisconsin Phase 4 2015-09-01 This study will evaluate the effectiveness of ketamine infusions in the management of acute pain resulting from broken ribs suffered following a blunt trauma. Half of patients will receive the institutional standard of care and a placebo infusion (no active medication). The other half of patients will receive the institutional standard of care and a ketamine infusion. All subjects and staff will be blinded as to whether they are receiving placebo or ketamine.
NCT05076110 ↗ Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures Not yet recruiting Mayo Clinic Phase 4 2021-12-01 This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ROBAXIN-750

Condition Name

Condition Name for ROBAXIN-750
Intervention Trials
Hip Arthroscopy 1
Rib Fractures 1
Wounds and Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ROBAXIN-750
Intervention Trials
Wounds and Injuries 1
Rib Fractures 1
Fractures, Bone 1
Acute Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ROBAXIN-750

Trials by Country

Trials by Country for ROBAXIN-750
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ROBAXIN-750
Location Trials
Minnesota 1
Wisconsin 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ROBAXIN-750

Clinical Trial Phase

Clinical Trial Phase for ROBAXIN-750
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ROBAXIN-750
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ROBAXIN-750

Sponsor Name

Sponsor Name for ROBAXIN-750
Sponsor Trials
Medical College of Wisconsin 1
Mayo Clinic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ROBAXIN-750
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.